1. Sanofi CEO Paul Hudson collects €11.34M in pay — Pandion's secret to moving a $65M Merck offer to a $1.9B done deal — Generics companies face risk as SCOTUS questions patent tribunal's constitutionality See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Roll over

Discussion in 'Exact Sciences' started by Anonymous, Jan 10, 2015 at 3:29 PM.

  1. Anonymous

    Anonymous Guest

    What's the real deal with the roll over? How many are going?
     
  2. Anonymous

    Anonymous Guest

    wait until feb you will not get a straight answer on here...
     
  3. Anonymous

    Anonymous Guest

    EXAS has a long way to go before they bring in decent $. I see them offering reps stock options that you can't exercise for a long time as one of big hooks to get people to stay. I would not count on much more.
     
  4. Anonymous

    Anonymous Guest

    Any hospital positions available yet?
     
  5. Anonymous

    Anonymous Guest


    They have direct hires from Exact maybe 25 nationwide doing hospitals it is not the main focus. The main focus is the PCP office market which is vital to Exact to get anywhere. If you want a job that is PCP office calls all the time this is it.
     
  6. Anonymous

    Anonymous Guest


    Primary care always pays bottom $ in terms of reps making $. They can't even get residents to do Primary Care since they know it does not pay well compared to everything except maybe Peds.